everlinQ Endovascular Access System Enhancements (EASE) Study

NCT03708770 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2025-12-11

Study results available
· View outcomes & findings →

Summary

Prospective, single-center study to evaluate the everlinQ System when used to create an endoAVF in hemodialysis patients.

Conditions

  • Chronic Kidney Diseases

Interventions

DEVICE

everlinQ endoAVF System

Sponsors & Collaborators

  • C. R. Bard

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-27
Primary Completion
2017-06-19
Completion
2017-06-19

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03708770 on ClinicalTrials.gov